| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 04/21/2011 | US20110091383 Fenretinide derivatives and uses thereof as therapeutic, diagnostic and imaging agents |
| 04/21/2011 | US20110091382 Novel imaging agents for detecting neurological dysfunction |
| 04/21/2011 | US20110091381 Gaba biomarkers for depression |
| 04/21/2011 | US20110091380 Chlorotoxins as drug carriers |
| 04/21/2011 | US20110091379 Method for treating tumors and their metastases |
| 04/21/2011 | US20110091378 Methods and Compositions for Treating Fibrosis Related Disorders Using IL-17 Antagonists |
| 04/21/2011 | US20110091377 Biomarkers for melanoma |
| 04/21/2011 | US20110091376 Catatonic steroid antimicrobial diagnostic, detection, screening and imaging methods |
| 04/21/2011 | US20110091375 Use of the combination comprising temozolomide and tnf-alpha for treating glioblastoma |
| 04/21/2011 | US20110091374 Contrast agents for applications including perfusion imaging |
| 04/21/2011 | US20110091373 Paa nanoparticles for enhancement of tumor imaging |
| 04/21/2011 | US20110091372 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 04/21/2011 | CA2776796A1 Porphyrin nanovesicles |
| 04/21/2011 | CA2775959A1 Dual variable domain immunoglobulins and uses thereof |
| 04/20/2011 | EP2311500A1 Labeling targeting agents with gallium-68 and gallium-67 |
| 04/20/2011 | EP2311490A2 Uses of antibodies to aminophospholipids for cancer treatment |
| 04/20/2011 | EP2311445A1 Methods of preventing, treating and diagnosing disorders of protein aggregation |
| 04/20/2011 | EP2311399A2 Method and apparatus for therapeutic EMR treatment of the skin |
| 04/20/2011 | EP2310055A2 Novel method for measuring insulin resistance |
| 04/20/2011 | EP1889834B1 Novel organic compound and method for producing radioactive halogen-labeled organic compound using the same |
| 04/20/2011 | EP1224461B1 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease |
| 04/20/2011 | CN102027019A High-density lipoprotein-like peptide-phospholipid scaffold (''HPPS'') nanoparticles |
| 04/20/2011 | CN102026671A Integrin targeting agents and in-vivo and in-vitro imaging methods using the same |
| 04/20/2011 | CN102026645A Oncolytic rhabdovirus |
| 04/20/2011 | CN102020768A 99mTc coordination compound, preparation method, intermediate and application thereof |
| 04/20/2011 | CN101585816B Benzene sulfonamide hydroxyl derivative and intermediate thereof as well as preparation method and application thereof |
| 04/20/2011 | CN101089020B VIP analog and its radioactive marker and their preparation process |
| 04/19/2011 | US7928056 Enzyme treatment of foodstuffs for Celiac Sprue |
| 04/19/2011 | US7927579 Tandem analyses of noncovalently driven effectors for modulatory mapping of activities of protein sites |
| 04/14/2011 | WO2011044422A2 Solid phase extraction purification method |
| 04/14/2011 | WO2011044410A2 Solid phase extraction purification method |
| 04/14/2011 | WO2011044406A2 Purification method |
| 04/14/2011 | WO2011043816A1 Phosphodiesterase 1-targeting tracers and methods |
| 04/14/2011 | WO2011042550A1 [18 f] - labelled analogues of flumazenil as in vivo imaging agents |
| 04/14/2011 | US20110086064 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 04/14/2011 | US20110085975 Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof |
| 04/14/2011 | US20110085974 Small molecule ligand-drug conjugates for targeted cancer therapy |
| 04/14/2011 | US20110085973 Methods and Agents for the Diagnosis and Treatment of Hepatocellular Carcinoma |
| 04/14/2011 | US20110085972 Nanotubes for cancer therapy and diagnostics |
| 04/14/2011 | US20110085971 Nanotubes for cancer therapy and diagnostics |
| 04/14/2011 | US20110085970 Anti-b7h4 monoclonal antibody-drug conjugate and methods of use |
| 04/14/2011 | US20110085969 Chelator-targeting ligand conjugates for cardiovascular imaging |
| 04/14/2011 | US20110085968 Articles comprising nano-materials for geometry-guided stem cell differentiation and enhanced bone growth |
| 04/14/2011 | CA2785179A1 Purification method |
| 04/14/2011 | CA2775573A1 Generation, characterization and uses thereof of anti-her 3 antibodies |
| 04/13/2011 | EP1237584B1 Receptor binding conjugates |
| 04/13/2011 | CN1693415B Hydroxy phosphorite of near infrared fluorescence quantum point mark and its preparation process and application |
| 04/13/2011 | CN102015768A Use of a radioactively labelled molecule specifically binding to ED-B fibronectin in a method of hodgkin lymphoma |
| 04/13/2011 | CN102015742A Metal complexes |
| 04/13/2011 | CN102014970A 99mTc-labeled 19 amino acid containing peptide for use as phosphatidylethanolamine binding molecular probe and radiopharmaceutical |
| 04/13/2011 | CN102014968A Therapy selection method |
| 04/13/2011 | CN102011120A Process for preparing silver based iodine-plated-125 source rod |
| 04/13/2011 | CN101554481B Dual-functional imaging agent for SPECT and MRI and preparation method thereof |
| 04/13/2011 | CN101475595B 99TcmN nuclear marker nitro glyoxaline xanthate complexes, as well as preparation method and use thereof |
| 04/12/2011 | US7923543 Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer |
| 04/12/2011 | US7922998 bombesin, derivatives and/or analogues capable of complexing metal ions, radionuclides or optical labels, for use in radiotherapy |
| 04/07/2011 | WO2011041319A2 Specific binding proteins and uses thereof |
| 04/07/2011 | WO2011040574A1 Method for producing azetidinylmethoxypyridine derivative and use of azetidinylmethoxypyridine derivative |
| 04/07/2011 | WO2011040460A1 Molecular probe for pancreatic islet imaging and use of said probe |
| 04/07/2011 | WO2011039626A1 Kit for dosing and delivering of radioactive drugs |
| 04/07/2011 | US20110082280 Methods Of Coupling Multidentate AZA Ligands To Targeting Molecules |
| 04/07/2011 | US20110081293 Methods and compositions related to clot-binding lipid compounds |
| 04/07/2011 | US20110081292 Methods Of Treating Viral Hepatitis |
| 04/06/2011 | EP2306187A1 Cancer eradication program |
| 04/06/2011 | EP2305316A2 Diphosphorylated glycopeptide imaging agent for fibrosis |
| 04/06/2011 | EP2305214A1 Novel molecular assembly, molecular probe for molecular imaging and molecular probe for drug delivery system using the same, and molecular imaging system and drug delivery system |
| 04/06/2011 | EP2305213A2 The treatment of small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 04/06/2011 | EP2303924A2 Lm-antibodies, functional fragments, lm-1 target antigen, and methods for making and using same |
| 04/06/2011 | EP2303337A1 Small molecule ligand-drug conjugates for targeted cancer therapy |
| 04/06/2011 | EP2303026A1 Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods |
| 04/06/2011 | EP1430071B1 Secreted and cell surface genes expressed in benign and malignant colorectal tumors |
| 04/06/2011 | CN101143897B Labeling technique for 99Tcm-His10-AnnexinV labeling compound and application of the same as developer in detecting cell apoptosis |
| 04/05/2011 | US7919607 Nucleic acids encoding humanized anti-tag 72 CC49 antbodies |
| 04/05/2011 | US7919578 Methods and compositions for inhibition of BCL6 repression |
| 04/05/2011 | US7919462 Inhibitors of human plasmin derived from the Kunitz domains |
| 04/05/2011 | US7919455 Marked peptides having affinity for a phospholipid and uses |
| 04/05/2011 | US7919090 Antibody therapy |
| 04/05/2011 | US7919072 Nanoparticles for protein drug delivery |
| 04/05/2011 | US7919071 Contrast agent |
| 03/31/2011 | WO2011037615A1 Chemical production module and dose synthesis card for pet biomarker production system |
| 03/31/2011 | WO2010106166A3 Radiolabelled pyridinyl derivatives for in-vivo imaging |
| 03/31/2011 | US20110077682 Hemorrhage Control Devices and Methods |
| 03/31/2011 | US20110076233 Delivery System for Cytotoxic Drugs by Bispecific Antibody Pretargeting |
| 03/31/2011 | US20110076232 Specific binding proteins and uses thereof |
| 03/31/2011 | US20110076231 Temporary embolization using inverse thermosensitive polymers |
| 03/31/2011 | US20110076230 Novel Substituted Indoles |
| 03/31/2011 | CA2775034A1 Chemical production module and dose synthesis card for pet biomarker production system |
| 03/30/2011 | EP2301971A1 Antibodies that bind both BCMA and TACI |
| 03/30/2011 | EP2301968A2 Humanized monoclonal antibody HPAM4 |
| 03/30/2011 | EP2301587A2 KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
| 03/30/2011 | EP2301581A1 Production and use of novel peptide-based agents for use with B1-specific antibodies |
| 03/30/2011 | EP2301570A1 Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated and conjugated antibodies, antibody combinations and fusion proteins |
| 03/30/2011 | EP2300057A2 18f-labelled three-and four-carbon acids for pet imaging |
| 03/30/2011 | EP2300045A1 Treatment of metastatic tumors |
| 03/30/2011 | EP2299849A2 Fluid bed meal containing a marker and methods of making |
| 03/30/2011 | EP1486785B1 Test agents for evaluating pharmacological effect of drug, and method and reagents for screening drug having excellent administration effect and/or little side effect from among drugs comprising enzymes, enzyme inhibitors or receptor ligands and/or prodrugs thereof |
| 03/30/2011 | CN101998956A Fluorinated dihydrotetrabenazine ether imaging agents and probes |
| 03/30/2011 | CN101991869A Chinese medicament capable of safely transforming human immunodeficiency virus (HIV) antibodies of acquired immune deficiency syndrome (AIDS) patient to be negative by utilizing uranium fission effect |
| 03/30/2011 | CN101555229B Nitro imidazole xanthogenate complex marked by <99>Tc<m>O, preparation method and applications |
| 03/30/2011 | CN101085787B Technetium-99m signed dimercaptosuccinate complexes, preparing method and application thereof |